Technology

Edwards Lifesciences Corp. announced U.S. Food and Drug Administration (FDA) approval of the Edwards Sapien 3 valve with the Commander Delivery System for the treatment of high-risk patients suffering from severe, symptomatic aortic stenosis.

Home June 19, 2015
Home
News | Wearables

ERT announced the integration of a wearable biosensor which captures and wirelessly transmits real-time, continuous, clinical-grade biometric measurements into the ERT electronic Clinical Outcome Assessment (eCOA) system. ERT showcased a proof-of-concept demonstration of the integration at its Innovation Lab at the Drug Information Association (DIA) Annual Meeting, June 14-17, in Washington, D.C.

Home June 19, 2015
Home
Technology

GE Healthcare announced the launch of its new introductory dose management solution, DoseWatch Explore, which is now available on select GE computed tomography (CT) systems in the United States. DoseWatch Explore is a Web-based, cloud-deployed, dose management software that tracks, analyzes and reports practice-level radiation dose data for GE CT systems.

Home June 18, 2015
Home
Technology

Calgary Scientific Inc. announced the release of ResolutionMD 5.1. The latest software version enables physicians to make faster and more informed treatment decisions, by providing even greater access to medical images and information via Web and mobile devices.

Home June 18, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

Atrial fibrillation patients on the anticoagulant dabigatran were more likely to adhere to the medication with appropriate patient selection and pharmacist-led monitoring, according to a study in the April 14 issue of JAMA. The study looked at patients who filled dabigatran prescriptions at Veterans Health Administration (VHA) sites, and found variability in patient medication adherence across sites.

Home June 18, 2015
Home
News | Stents

Stentys announced in April that it received CE Marking for its new Self-Apposing stent system ahead of plan. The designation will allow the company to market the new products in Europe and in all the other countries where this certification is recognized. The Xposition S stent officially launched at the EuroPCR conference on May 19, 2015.

Home June 18, 2015
Home
News | Cardiovascular Business

IMRIS Inc. received a letter May 26 from the NASDAQ Stock Market stating that it would be delisted and trading suspended on June 4. IMRIS said this was in accordance with Listing Rules 5101, 5110(b), and IM-5101-1. A Form 25-NSE will be filed with the Securities and Exchange Commission (the SEC), which will remove the company's securities from listing and registration on The Nasdaq Stock Market.

Home June 18, 2015
Home
Technology

Toshiba America Medical Systems Inc. has received U.S. Food and Drug Administration (FDA) clearance for detector and computed tomography (CT) software enhancements for its Aquilion ONE family of CT systems. which are designed to offer customers the right technology to meet their business needs for improving patient safety, have received FDA clearance.

Home June 18, 2015
Home
Videos | Cardiovascular Ultrasound

Role of Interventional Echcardiography in Transcatheter Structural Heart Procedures — Rebecca Hahn, M.D., Columbia ...

Home June 17, 2015
Home
News | Stents Carotid

Karam Moon, M.D., winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, presented his research, The Myth of Restenosis after Carotid Angioplasy and Stenting, at the American Association of Neurological Surgeons (AANS) annual scientific meeting in May.

Home June 17, 2015
Home
Videos | Structural Heart

Interview with Ted Feldman, M.D., FACC, MSCAI, FESC, cardiac cath lab director, Evanston Hospital, North Shore Health ...

Home June 17, 2015
Home
Videos | Heart Valve Technology

Interview with Michael Reardon, M.D., professor of cardiothoracic surgery at DeBakey Heart and Vascular Center, and ...

Home June 17, 2015
Home
Videos | Heart Valve Technology

Interview with Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research ...

Home June 17, 2015
Home
News | Stents Drug Eluting

Stentys announced that the findings of the first Xposition clinical experience, as part of the SETUP trial, were presented at the EuroPCR conference in May. The results of this study were also published in the online edition of EuroIntervention.

Home June 17, 2015
Home
Videos | Heart Valve Technology

Interview with Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research ...

Home June 17, 2015
Home
Subscribe Now